CLSLPesticides & Agrochemicals
Crop Life Science Ltd — Cash Flow Statement
₹41.00
-6.82%
Crop Life Science Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -6.00 Cr | -15.77 Cr | -2.74 Cr | -4.51 Cr | — |
| Issuance Of Capital Stock | 0.00 | 25.11 Cr | — | — | — |
| Capital Expenditure | -3.90 Cr | -7.44 Cr | -5.02 Cr | -4.37 Cr | — |
| End Cash Position | 0.95 Cr | 2.39 Cr | 0.38 Cr | 2.07 Cr | — |
| Beginning Cash Position | 2.39 Cr | 0.72 Cr | 2.07 Cr | 3.09 Cr | — |
| Changes In Cash | -1.44 Cr | 1.67 Cr | -1.69 Cr | -1.02 Cr | — |
| Financing Cash Flow | 4.16 Cr | 13.43 Cr | 0.52 Cr | 1.11 Cr | — |
| Net Other Financing Charges | 100.00 | 0.32 Cr | — | — | — |
| Interest Paid Cff | -4.75 Cr | -4.67 Cr | -3.27 Cr | -2.07 Cr | — |
| Net Common Stock Issuance | 0.00 | 25.11 Cr | — | — | — |
| Common Stock Issuance | 0.00 | 25.11 Cr | — | — | — |
| Net Issuance Payments Of Debt | 9.32 Cr | -6.23 Cr | 5.08 Cr | 3.46 Cr | — |
| Net Short Term Debt Issuance | 10.04 Cr | 6.13 Cr | -0.77 Cr | 4.42 Cr | — |
| Net Long Term Debt Issuance | -0.73 Cr | -12.36 Cr | 5.85 Cr | -0.96 Cr | — |
| Investing Cash Flow | -3.50 Cr | -3.42 Cr | -4.48 Cr | -1.99 Cr | — |
| Interest Received Cfi | 0.38 Cr | 1.36 Cr | 0.53 Cr | 89000.00 | — |
| Net PPE Purchase And Sale | -3.88 Cr | -4.78 Cr | -5.02 Cr | -2.00 Cr | — |
| Sale Of PPE | 0.02 Cr | 2.66 Cr | 0.00 | 2.37 Cr | — |
| Purchase Of PPE | -3.90 Cr | -7.44 Cr | -5.02 Cr | -4.37 Cr | — |
| Operating Cash Flow | -2.10 Cr | -8.33 Cr | 2.27 Cr | -0.15 Cr | — |
| Taxes Refund Paid | -2.17 Cr | -2.14 Cr | -1.75 Cr | -1.02 Cr | — |
| Change In Working Capital | -16.82 Cr | -19.69 Cr | -7.77 Cr | -7.41 Cr | — |
| Change In Other Current Liabilities | -1.34 Cr | -0.48 Cr | -0.09 Cr | -0.15 Cr | — |
| Change In Other Current Assets | -3.75 Cr | 6.89 Cr | -6.19 Cr | -5.79 Cr | — |
| Change In Payable | -11.30 Cr | 32.64 Cr | -2.24 Cr | 2.30 Cr | — |
| Change In Inventory | -9.08 Cr | -13.63 Cr | -3.93 Cr | 7.11 Cr | — |
| Change In Receivables | 8.21 Cr | -45.51 Cr | 4.55 Cr | -11.02 Cr | — |
| Other Non Cash Items | 4.38 Cr | 3.28 Cr | 2.74 Cr | 2.06 Cr | — |
| Provisionand Write Offof Assets | -0.11 Cr | 0.70 Cr | -0.25 Cr | 0.24 Cr | — |
| Depreciation And Amortization | 4.83 Cr | 4.42 Cr | 3.71 Cr | 2.25 Cr | — |
| Depreciation | 4.83 Cr | 4.42 Cr | 3.71 Cr | 2.13 Cr | — |
| Gain Loss On Sale Of PPE | 9000.00 | -0.50 Cr | 0.00 | -0.04 Cr | — |
| Net Income From Continuing Operations | 7.80 Cr | 5.60 Cr | 5.60 Cr | 3.77 Cr | — |
| Amortization Cash Flow | — | — | — | 0.12 Cr | 0.12 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Crop Life Science Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.